Personal information

No personal information available

Activities

Collapse all

Employment (2)

Yale New Haven Hospital: New Haven, US

2024-07-01 to present | Medical Oncology Fellow (Smilow Cancer Hospital)
Employment
Source: Self-asserted source
Xuanyi Li

Vanderbilt University Medical Center: Nashville, Tennessee, US

2021-07-01 to 2024-06-30 | Resident physician (Internal Medicine)
Employment
Source: Self-asserted source
Xuanyi Li

Education and qualifications (2)

Vanderbilt University School of Medicine: Nashville, Tennessee, US

2017 to 2021 | Doctor of Medicine
Education
Source: Self-asserted source
Xuanyi Li

University of Notre Dame: Notre Dame, IN, US

2012 to 2016 | Bachelor of Science in Computer Science (Department of Engineering)
Education
Source: Self-asserted source
Xuanyi Li

Works (6)

Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Blood cancer discovery
2022-05-01 | Journal article
DOI: 10.1158/2643-3230.bcd-22-0013
PMID: 35262738
Contributors: Xuanyi Li
Source: Self-asserted source
Xuanyi Li

Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.

JAMA network open
2022-04-01 | Journal article
DOI: 10.1001/jamanetworkopen.2022.4361
PMID: 35416993
PMC: PMC9008500
Contributors: Xuanyi Li
Source: Self-asserted source
Xuanyi Li

Precision Cancer Medicine: Dynamic Learning of Cancer Biology in a Clinically Meaningful Context.

Medical science educator
2021-04-02 | Journal article
DOI: 10.1007/s40670-021-01267-1
PMID: 34457947
PMC: PMC8368858
Contributors: Xuanyi Li
Source: Self-asserted source
Xuanyi Li

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Annals of oncology : official journal of the European Society for Medical Oncology
2021-03-19 | Journal article
DOI: 10.1016/j.annonc.2021.02.024
PMID: 33746047
PMC: PMC7972830
Contributors: Grivas P; Khaki AR; Wise-Draper TM; French B; Hennessy C; Hsu CY; Shyr Y; Li X; Toni Choueiri; Painter CA et al.
Source: Self-asserted source
Xuanyi Li

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis.

Scientific reports
2020-10-16 | Journal article
DOI: 10.1038/s41598-020-73466-6
PMID: 33067482
PMC: PMC7568560
Contributors: Xuanyi Li
Source: Self-asserted source
Xuanyi Li

A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants

Frontiers in Cell and Developmental Biology
2020-02-11 | Journal article
DOI: 10.3389/fcell.2020.00048
Part of ISSN: 2296-634X
Source: Self-asserted source
Xuanyi Li
How many people are using ORCID?